Demonstrates selective Cu2+ detection in metal sensors, suggesting improved sensing technology.
The need for rapid, selective, and ultra-sensitive detection of metal-ion has driven extensive research into chemosensor design. Ruthenium(II) complexes, with their unique luminescence, redox activity, and photostability, have become attractive candidates for ion sensing. Quinoline-based ligands, when incorporated into ruthenium(II) frameworks, can provide a rigid coordination environment with extended π-conjugation which enhances the sensing performance. The current investigation concentrates on the design and synthesis of a novel [Ru(pqyCOOH)3]2+ ((pqyCOOH) = 2-(pyridine-2-yl)-quinoline-4-carboxylic acid) complex for a selective luminescent sensor for Cu2+ ions. The [Ru(pqyCOOH)3]2+ complex is characterized using UV-Visible, emission, FTIR, 1H NMR, 13C NMR and MALDI-TOF mass spectral techniques. The UV-Visible titration of the complex with Cu2+ ions displays a notable colour change forming a stable 1:1 Ru(II)-quinoline-Cu2+ adduct with a binding constant of 4.8× 105 M-1. Benesi-Hildebrand plot reveals a linear response, with the detection limit of 1.5×10-5 M. Selectivity tests demonstrate minimal interference from other metal ions such as Ba2+, Li+, Fe3+, Mg2+, Cd2+, Zn2+, Co2+, Ni2+ and Zr2+, confirming the probes specificity for Cu2+. This work expands the scope of Ru(II) based luminescent chemosensors and highlights the synergistic advantage of integrating quinoline ligands with Ru(II) centers for copper detection.
No takes yet. Share an insight, caveat, or question.
Thev et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: